Biohaven Ltd (BHVN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -10,066 | N/A |
| Accounts payable and accrued liabilities | 23 | N/A |
| Other Working Capital | -261 | N/A |
| Other Operating Activity | 4,679 | 0 |
| Operating Cash Flow | $-5,625 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -3 | N/A |
| Investing Cash Flow | $-3 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 4,853 | N/A |
| Other Financing Activity | 463 | 0 |
| Financing Cash Flow | $5,316 | $N/A |
| Beginning Cash Position | 1,772 | N/A |
| End Cash Position | 1,460 | N/A |
| Net Cash Flow | $-312 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -5,625 | N/A |
| Capital Expenditure | -3 | N/A |
| Free Cash Flow | -5,628 | 0 |